Sohanya Roshan Cheng, Chief Commercial Officer at Karyopharm Therapeutics Inc. (KPTI), sold 1,551 shares at $5.20 ($8K) on 2022-06-13, disclosed to the SEC on 2022-06-14.
Open-market sale of $8k KPTI by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.20 | 1,485 | $8K | 95.6% |
| 2 | $5.35 | 66 | $353 | 4.4% |
| Total | $5.21 avg | 1,551 | $8K | 100% |
| Filing → |
| KPTI | SELL | 2025-09-16 | $2K | — | Filing → |
| KPTI | SELL | 2025-03-06 | $22K | — | Filing → |
| KPTI | SELL | 2024-09-05 | $4K | — | Filing → |